Skip to content
NBDC Human Database

No datasets in the cart.

Due to system maintenance, the application system, application review by the Data Access Committee will be unavailable during the following period.
Schedule: October 5th (Mon), 2026, 9:00 - October 7th (Wed), 2026, 15:00 (JST)
We apologize for any inconvenience this may cause and appreciate your understanding.

We are currently receiving a large number of applications for data submission, and the review process is taking longer than usual.We sincerely apologize for the delay and kindly ask for your understanding. When submitting an application, we would greatly appreciate it if you could allow sufficient time for the processing.

Following a change to our organizational structure effective April 1, 2026, this division has been renamed from the "Database Center for Life Science, Joint Support-Center for Data Science Research" to the "Database Division for Life Science (DBCLS), BioData Science Initiative (BSI), National Institute of Genetics (NIG)". Where the former name still appears in the guidelines, please read it as the new name.

Dataset ID

JGAD001038

Type of data
NGS (Exome, RNA-seq)
Access criteria
Controlled-access (Type I)
Total data volume
325 GB
File formats
  • FASTQ
Research
hum0563
Date published
2026-04-16
Date modified
2026-04-16

Analysis method

WES

Materials and participants
gastric cancer (ICD10: C16): 10 cases
paired tumor and non-tumor tissues (peripheral blood): 20 samples
  • Health status
    Affected
  • Subject count
    10 (Individual)
Disease
gastric cancer (C16)
Sample description
DNA extracted from tumor tissues and peripheral blood cells
  • Tissue
    Peripheral blood, Stomach
  • Tumor / normal
    Mixed
Sample provider
N/A
Experimental method
WES
Target
N/A
Reagent kit
SureSelect Human All Exon V6
Fragmentation
Ultrasonic fragmentation
Platform
Illumina NovaSeq 6000
Read type
Paired-end
Read length
150 bp

RNA-seq

Materials and participants
gastric cancer (ICD10: C16): 9 cases
tumor tissues:
pre-treatment 9 samples
after treatment 8 samples
total 17 samples
  • Health status
    Affected
  • Subject count
    9 (Individual)
Disease
gastric cancer (C16)
Sample description
RNA extracted from tumor tissues
  • Tissue
    Stomach
  • Tumor / normal
    Tumor
Sample provider
N/A
Experimental method
RNA-seq
Target
N/A
Reagent kit
TruSeq Stranded mRNA Library Prep Kit
Fragmentation
chemical fragmentation
Platform
Illumina NovaSeq 6000
Read type
Single-end
Read length
100 bp